BIOFRONTERA INC (BFRI) Fundamental Analysis & Valuation

NASDAQ:BFRI • US09077D2099

Current stock price

0.861 USD
-0.01 (-0.99%)
Last:

This BFRI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. BFRI Profitability Analysis

1.1 Basic Checks

  • In the past year BFRI has reported negative net income.
  • BFRI had a negative operating cash flow in the past year.
  • BFRI had negative earnings in each of the past 5 years.
  • BFRI had a negative operating cash flow in each of the past 5 years.
BFRI Yearly Net Income VS EBIT VS OCF VS FCFBFRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

  • BFRI's Return On Assets of -113.99% is on the low side compared to the rest of the industry. BFRI is outperformed by 77.08% of its industry peers.
Industry RankSector Rank
ROA -113.99%
ROE N/A
ROIC N/A
ROA(3y)-51.23%
ROA(5y)-54.01%
ROE(3y)-274.43%
ROE(5y)-268.87%
ROIC(3y)N/A
ROIC(5y)N/A
BFRI Yearly ROA, ROE, ROICBFRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

  • The Gross Margin of BFRI (64.41%) is better than 72.92% of its industry peers.
  • In the last couple of years the Gross Margin of BFRI has remained more or less at the same level.
  • BFRI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.08%
GM growth 5Y-0.95%
BFRI Yearly Profit, Operating, Gross MarginsBFRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. BFRI Health Analysis

2.1 Basic Checks

  • BFRI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • BFRI has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for BFRI has been increased compared to 5 years ago.
  • BFRI has a worse debt/assets ratio than last year.
BFRI Yearly Shares OutstandingBFRI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
BFRI Yearly Total Debt VS Total AssetsBFRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

  • Based on the Altman-Z score of -13.01, we must say that BFRI is in the distress zone and has some risk of bankruptcy.
  • BFRI has a worse Altman-Z score (-13.01) than 77.60% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -13.01
ROIC/WACCN/A
WACC17.56%
BFRI Yearly LT Debt VS Equity VS FCFBFRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

  • BFRI has a Current Ratio of 1.15. This is a normal value and indicates that BFRI is financially healthy and should not expect problems in meeting its short term obligations.
  • BFRI's Current ratio of 1.15 is on the low side compared to the rest of the industry. BFRI is outperformed by 80.21% of its industry peers.
  • A Quick Ratio of 0.80 indicates that BFRI may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.80, BFRI is doing worse than 80.73% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.15
Quick Ratio 0.8
BFRI Yearly Current Assets VS Current LiabilitesBFRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. BFRI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 66.55% over the past year.
  • The Revenue has been growing slightly by 5.11% in the past year.
  • Measured over the past years, BFRI shows a small growth in Revenue. The Revenue has been growing by 7.35% on average per year.
EPS 1Y (TTM)66.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.73%
Revenue 1Y (TTM)5.11%
Revenue growth 3Y15.69%
Revenue growth 5Y7.35%
Sales Q2Q%-22.46%

3.2 Future

  • Based on estimates for the next years, BFRI will show a very strong growth in Earnings Per Share. The EPS will grow by 26.71% on average per year.
  • BFRI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.86% yearly.
EPS Next Y65.92%
EPS Next 2Y40.68%
EPS Next 3Y26.71%
EPS Next 5YN/A
Revenue Next Year3.66%
Revenue Next 2Y7.25%
Revenue Next 3Y10.94%
Revenue Next 5Y14.86%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BFRI Yearly Revenue VS EstimatesBFRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 20M 40M 60M 80M 100M
BFRI Yearly EPS VS EstimatesBFRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -10 -20 -30 -40 -50

More info and screens

Find the best growth stocksShow best growing peers

1

4. BFRI Valuation Analysis

4.1 Price/Earnings Ratio

  • BFRI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BFRI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BFRI Price Earnings VS Forward Price EarningsBFRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BFRI Per share dataBFRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

  • BFRI's earnings are expected to grow with 26.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.68%
EPS Next 3Y26.71%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BFRI Dividend Analysis

5.1 Amount

  • BFRI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BFRI Fundamentals: All Metrics, Ratios and Statistics

BIOFRONTERA INC

NASDAQ:BFRI (3/16/2026, 9:36:51 AM)

0.861

-0.01 (-0.99%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-12
Earnings (Next)03-19
Inst Owners17.2%
Inst Owner Change-0.63%
Ins Owners4.7%
Ins Owner Change21.28%
Market Cap10.03M
Revenue(TTM)37.16M
Net Income(TTM)-17.57M
Analysts82.5
Price Target6.12 (610.8%)
Short Float %1.59%
Short Ratio0.27
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-18.93%
Min EPS beat(2)-33.05%
Max EPS beat(2)-4.8%
EPS beat(4)0
Avg EPS beat(4)-258.14%
Min EPS beat(4)-880.39%
Max EPS beat(4)-4.8%
EPS beat(8)1
Avg EPS beat(8)-142.95%
EPS beat(12)1
Avg EPS beat(12)-106.93%
EPS beat(16)4
Avg EPS beat(16)-70.42%
Revenue beat(2)1
Avg Revenue beat(2)2.27%
Min Revenue beat(2)-2.13%
Max Revenue beat(2)6.66%
Revenue beat(4)1
Avg Revenue beat(4)-7.73%
Min Revenue beat(4)-20.19%
Max Revenue beat(4)6.66%
Revenue beat(8)1
Avg Revenue beat(8)-10.92%
Revenue beat(12)2
Avg Revenue beat(12)-8.47%
Revenue beat(16)2
Avg Revenue beat(16)-7.07%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)30%
EPS NY rev (1m)3.47%
EPS NY rev (3m)7.95%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.92%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.52%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.27
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.91
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)-1.03
FCFYN/A
OCF(TTM)-1.03
OCFYN/A
SpS3.19
BVpS-0.22
TBVpS-0.22
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -113.99%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.41%
FCFM N/A
ROA(3y)-51.23%
ROA(5y)-54.01%
ROE(3y)-274.43%
ROE(5y)-268.87%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.08%
GM growth 5Y-0.95%
F-Score3
Asset Turnover2.41
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr -0.93%
Cap/Sales 0.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.15
Quick Ratio 0.8
Altman-Z -13.01
F-Score3
WACC17.56%
ROIC/WACCN/A
Cap/Depr(3y)7.65%
Cap/Depr(5y)4.96%
Cap/Sales(3y)0.1%
Cap/Sales(5y)0.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.73%
EPS Next Y65.92%
EPS Next 2Y40.68%
EPS Next 3Y26.71%
EPS Next 5YN/A
Revenue 1Y (TTM)5.11%
Revenue growth 3Y15.69%
Revenue growth 5Y7.35%
Sales Q2Q%-22.46%
Revenue Next Year3.66%
Revenue Next 2Y7.25%
Revenue Next 3Y10.94%
Revenue Next 5Y14.86%
EBIT growth 1Y8.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year56.04%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y50.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.61%
OCF growth 3YN/A
OCF growth 5YN/A

BIOFRONTERA INC / BFRI Fundamental Analysis FAQ

What is the fundamental rating for BFRI stock?

ChartMill assigns a fundamental rating of 2 / 10 to BFRI.


What is the valuation status for BFRI stock?

ChartMill assigns a valuation rating of 1 / 10 to BIOFRONTERA INC (BFRI). This can be considered as Overvalued.


What is the profitability of BFRI stock?

BIOFRONTERA INC (BFRI) has a profitability rating of 1 / 10.


What is the expected EPS growth for BIOFRONTERA INC (BFRI) stock?

The Earnings per Share (EPS) of BIOFRONTERA INC (BFRI) is expected to grow by 65.92% in the next year.